ACE and cardiovascular disorder: For cardiovascular diseases, most of the study participants (16%, n = 36) were on beta-blockers, followed by angiotensin-receptor blockers 14.7% (n = 33), angiotensin-converting enzyme inhibitors 7.6% (n = 17), calcium channel blockers 9.8% (n = 22), and diuretics 7.1% (n = 16).